Therapeutic use of 20-kilodalton human growth hormone
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 4, 2002
Issued Date -
N/A
app pub date -
Dec 15, 1997
filing date -
Jun 29, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Administration of an administrative amount of an authentic human growth hormone having a molecular weight of 20,000 daltons to human adults can improve body composition, stimulate lipolysis, increase serum insulin-like growth factor I or be used in replacement therapy for human growth hormone-deficient patients.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully